Major industry players operating in the aptamers market include
SomaLogic
Aptamer Group
Aptadel Therapeutics
Base Pair Biotechnologies
Vivonics Inc.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global market size for aptamers was USD 2.9 billion in 2023 and will reach USD 15.1 billion by 2032 due to their growing advantages over traditional antibodies.
DNA-based market registered 63.4% revenue share in 2022 and is expected to witness significant growth by 2032 impelled by its escalating demand in versatile and well-established platforms.
North America held 43.6% of the aptamers industry share in 2022 and will witness substantial CAGR through 2032 due to the increasing presence of well-established pharmaceutical and biotechnology industry in the region.